Melgisorb Ag Antimicrobial Alginate Dressings

£33.39
In stock
Size

Melgisorb Ag is a sterile, highly absorbent antimicrobial alginate dressing containing ionic silver, designed for the management of moderately to heavily exuding wounds where infection is present or there is an increased risk of infection.

The dressing combines high-G calcium alginate and carboxymethylcellulose (CMC) with an ionic silver complex. As wound exudate is absorbed, the alginate fibres form a soft gel that helps maintain a moist wound-healing environment and supports autolytic debridement. At the same time, silver ions are released into the wound environment, providing broad-spectrum antimicrobial activity.

Key features:

  • Highly absorbent antimicrobial alginate dressing
  • Contains ionic silver
  • Designed for moderately to heavily exuding wounds
  • Helps reduce wound bioburden
  • Broad-spectrum antimicrobial activity
  • Silver ions are released when the dressing comes into contact with wound exudate
  • Current Mölnlycke UK information reports antimicrobial activity against a broad spectrum of microorganisms for up to 21 days in vitro
  • Forms a soft gel as it absorbs exudate
  • Helps maintain a moist wound-healing environment
  • Supports autolytic debridement
  • High wet strength helps facilitate removal
  • May help control minor bleeding from superficial wounds due to its alginate content
  • May help reduce wound odour associated with infection
  • Acts as a barrier against penetration by microorganisms
  • Can be cut or folded to fit the wound
  • Cavity dressing available for deeper wounds
  • Can be used under compression bandaging
  • Requires an appropriate secondary dressing
  • Sterile
  • Single use

The manufacturer's antimicrobial-duration data are in-vitro results and should not be interpreted as dressing wear time.

Suitable for:

Melgisorb Ag is indicated for the management of moderately to heavily exuding partial- to full-thickness wounds, including:

  • Post-operative surgical wounds
  • Traumatic wounds
  • Dermal lesions
  • Traumatic injuries and incisions
  • Leg ulcers
  • Pressure ulcers
  • Diabetic ulcers
  • Graft sites
  • Donor sites
  • Cavity wounds
  • Superficial and partial-thickness burns
  • Infected wounds
  • Wounds with an increased risk of infection

Melgisorb Ag may be used in the management of infected wounds or wounds at increased risk of infection under the supervision of a healthcare professional.

Composition:

Melgisorb Ag is a sterile non-woven dressing containing:

  • High-G calcium alginate
  • Carboxymethylcellulose (CMC)
  • Ionic silver complex – Silver Sodium Hydrogen Zirconium Phosphate

In the presence of wound exudate, the dressing absorbs fluid and forms a gel. The ionic silver complex releases silver ions, providing antimicrobial activity within the wound environment.

How to use:

Debride the wound where necessary and cleanse or irrigate it according to the recommended wound-care protocol.

Remove excess cleansing solution from the surrounding skin.

Select a Melgisorb Ag dressing that is slightly larger than the wound.

The dressing can be cut or folded to fit the wound as required.

Apply Melgisorb Ag directly to the wound bed.

For deep or cavity wounds, loosely fill the wound with the cavity dressing. Do not tightly pack the wound and do not allow the dressing to unnecessarily overlap the wound margins.

Cover and secure with an appropriate secondary dressing suitable for the amount of wound exudate.

Dressing change frequency:

Dressing-change frequency depends on:

  • Amount of wound exudate
  • Condition of the wound
  • Infection status
  • Condition of the surrounding skin
  • Absorbency of the secondary dressing
  • Clinical assessment

Initially, it may be necessary to change Melgisorb Ag every 24 hours, particularly in highly exuding wounds.

As the wound improves and exudate decreases, dressing-change frequency may be reduced according to clinical assessment.

If Melgisorb Ag becomes dry or adheres to the wound, saturate it with sterile saline before removal, then gently remove it from the wound bed.

Available sizes:

  • 5cm × 5cm – pack of 10
    PIP Code: 346-8337
    NHS Supply Chain Code: ELS636
    Mölnlycke Ref: 256055
  • 10cm × 10cm – pack of 10
    PIP Code: 346-8345
    NHS Supply Chain Code: ELS648
    Mölnlycke Ref: 256105
  • 15cm × 15cm – pack of 10
    PIP Code: 346-8352
    NHS Supply Chain Code: ELS723
    Mölnlycke Ref: 256155
  • Melgisorb Ag Cavity 3cm × 44cm – pack of 10
    PIP Code: 346-8329
    NHS Supply Chain Code: ELS647
    Mölnlycke Ref: 256605

These are the presentations currently listed by Mölnlycke for the UK market.

Important information:

Do not use Melgisorb Ag in people with a known sensitivity or allergy to alginates, silver or any other component of the dressing.

Do not use:

  • Directly on dry or very lightly exuding wounds
  • To control heavy bleeding
  • For surgical implantation

Melgisorb Ag may assist with minor bleeding from superficial wounds, but it is not intended to control significant haemorrhage.

If the dressing adheres because the wound has become dry, moisten it thoroughly with sterile saline before attempting removal.

Excessive use of petroleum-based ointments may impair dressing performance.

Avoid contact with electrodes or conductive gels during electronic measurements such as ECG or EEG.

Melgisorb Ag must be removed before MRI examinations.

For clinically infected wounds, topical silver treatment does not replace systemic antimicrobial treatment or other appropriate infection management where this is clinically required.

There are limited data on prolonged or repeated use of silver-containing dressings, particularly in children and neonates. Mölnlycke advises clinical review where silver dressings are used for prolonged periods or over large surface areas.

Product type: Antimicrobial alginate wound dressing

Antimicrobial: Ionic silver

Dressing composition: Calcium alginate / CMC / ionic silver complex

Exudate level: Moderate to high

Wound depth: Superficial to deep / cavity wounds

Suitable for infected wounds: Yes, under appropriate healthcare-professional supervision

Forms a gel: Yes

Can be cut or folded: Yes

Use under compression: Yes, where clinically appropriate

Secondary dressing required: Yes

Sterility: Sterile

Single use: Yes

Available sizes: 5cm × 5cm / 10cm × 10cm / 15cm × 15cm / Cavity 3cm × 44cm

Pack size: 10 dressings

Manufacturer: Mölnlycke Health Care

Always follow the instructions supplied with the dressing and the wound-care advice provided by your doctor, nurse or other appropriately qualified healthcare professional.

 Product Information Leaflet 

Melgisorb Ag is a sterile, highly absorbent antimicrobial alginate dressing containing ionic silver, designed for the management of moderately to heavily exuding wounds where infection is present or there is an increased risk of infection.

The dressing combines high-G calcium alginate and carboxymethylcellulose (CMC) with an ionic silver complex. As wound exudate is absorbed, the alginate fibres form a soft gel that helps maintain a moist wound-healing environment and supports autolytic debridement. At the same time, silver ions are released into the wound environment, providing broad-spectrum antimicrobial activity.

Key features:

  • Highly absorbent antimicrobial alginate dressing
  • Contains ionic silver
  • Designed for moderately to heavily exuding wounds
  • Helps reduce wound bioburden
  • Broad-spectrum antimicrobial activity
  • Silver ions are released when the dressing comes into contact with wound exudate
  • Current Mölnlycke UK information reports antimicrobial activity against a broad spectrum of microorganisms for up to 21 days in vitro
  • Forms a soft gel as it absorbs exudate
  • Helps maintain a moist wound-healing environment
  • Supports autolytic debridement
  • High wet strength helps facilitate removal
  • May help control minor bleeding from superficial wounds due to its alginate content
  • May help reduce wound odour associated with infection
  • Acts as a barrier against penetration by microorganisms
  • Can be cut or folded to fit the wound
  • Cavity dressing available for deeper wounds
  • Can be used under compression bandaging
  • Requires an appropriate secondary dressing
  • Sterile
  • Single use

The manufacturer's antimicrobial-duration data are in-vitro results and should not be interpreted as dressing wear time.

Suitable for:

Melgisorb Ag is indicated for the management of moderately to heavily exuding partial- to full-thickness wounds, including:

  • Post-operative surgical wounds
  • Traumatic wounds
  • Dermal lesions
  • Traumatic injuries and incisions
  • Leg ulcers
  • Pressure ulcers
  • Diabetic ulcers
  • Graft sites
  • Donor sites
  • Cavity wounds
  • Superficial and partial-thickness burns
  • Infected wounds
  • Wounds with an increased risk of infection

Melgisorb Ag may be used in the management of infected wounds or wounds at increased risk of infection under the supervision of a healthcare professional.

Composition:

Melgisorb Ag is a sterile non-woven dressing containing:

  • High-G calcium alginate
  • Carboxymethylcellulose (CMC)
  • Ionic silver complex – Silver Sodium Hydrogen Zirconium Phosphate

In the presence of wound exudate, the dressing absorbs fluid and forms a gel. The ionic silver complex releases silver ions, providing antimicrobial activity within the wound environment.

How to use:

Debride the wound where necessary and cleanse or irrigate it according to the recommended wound-care protocol.

Remove excess cleansing solution from the surrounding skin.

Select a Melgisorb Ag dressing that is slightly larger than the wound.

The dressing can be cut or folded to fit the wound as required.

Apply Melgisorb Ag directly to the wound bed.

For deep or cavity wounds, loosely fill the wound with the cavity dressing. Do not tightly pack the wound and do not allow the dressing to unnecessarily overlap the wound margins.

Cover and secure with an appropriate secondary dressing suitable for the amount of wound exudate.

Dressing change frequency:

Dressing-change frequency depends on:

  • Amount of wound exudate
  • Condition of the wound
  • Infection status
  • Condition of the surrounding skin
  • Absorbency of the secondary dressing
  • Clinical assessment

Initially, it may be necessary to change Melgisorb Ag every 24 hours, particularly in highly exuding wounds.

As the wound improves and exudate decreases, dressing-change frequency may be reduced according to clinical assessment.

If Melgisorb Ag becomes dry or adheres to the wound, saturate it with sterile saline before removal, then gently remove it from the wound bed.

Available sizes:

  • 5cm × 5cm – pack of 10
    PIP Code: 346-8337
    NHS Supply Chain Code: ELS636
    Mölnlycke Ref: 256055
  • 10cm × 10cm – pack of 10
    PIP Code: 346-8345
    NHS Supply Chain Code: ELS648
    Mölnlycke Ref: 256105
  • 15cm × 15cm – pack of 10
    PIP Code: 346-8352
    NHS Supply Chain Code: ELS723
    Mölnlycke Ref: 256155
  • Melgisorb Ag Cavity 3cm × 44cm – pack of 10
    PIP Code: 346-8329
    NHS Supply Chain Code: ELS647
    Mölnlycke Ref: 256605

These are the presentations currently listed by Mölnlycke for the UK market.

Important information:

Do not use Melgisorb Ag in people with a known sensitivity or allergy to alginates, silver or any other component of the dressing.

Do not use:

  • Directly on dry or very lightly exuding wounds
  • To control heavy bleeding
  • For surgical implantation

Melgisorb Ag may assist with minor bleeding from superficial wounds, but it is not intended to control significant haemorrhage.

If the dressing adheres because the wound has become dry, moisten it thoroughly with sterile saline before attempting removal.

Excessive use of petroleum-based ointments may impair dressing performance.

Avoid contact with electrodes or conductive gels during electronic measurements such as ECG or EEG.

Melgisorb Ag must be removed before MRI examinations.

For clinically infected wounds, topical silver treatment does not replace systemic antimicrobial treatment or other appropriate infection management where this is clinically required.

There are limited data on prolonged or repeated use of silver-containing dressings, particularly in children and neonates. Mölnlycke advises clinical review where silver dressings are used for prolonged periods or over large surface areas.

Product type: Antimicrobial alginate wound dressing

Antimicrobial: Ionic silver

Dressing composition: Calcium alginate / CMC / ionic silver complex

Exudate level: Moderate to high

Wound depth: Superficial to deep / cavity wounds

Suitable for infected wounds: Yes, under appropriate healthcare-professional supervision

Forms a gel: Yes

Can be cut or folded: Yes

Use under compression: Yes, where clinically appropriate

Secondary dressing required: Yes

Sterility: Sterile

Single use: Yes

Available sizes: 5cm × 5cm / 10cm × 10cm / 15cm × 15cm / Cavity 3cm × 44cm

Pack size: 10 dressings

Manufacturer: Mölnlycke Health Care

Always follow the instructions supplied with the dressing and the wound-care advice provided by your doctor, nurse or other appropriately qualified healthcare professional.

 Product Information Leaflet